what is better semaglutide or tirzepatide for weight loss vs Semaglutide vs. Tirzepatide: What's the

N Engl J Med 2025;393:1796-1806 [9] Lilly's triple agonist, retatrutide, delivered weight loss of up to an average of 71.2 lbs along with substantial relief from osteoarthritis pain in first successful Phase 3 trial, December 2025: Lilly's triple agonist, retatrutide, delivered weight loss of up to an average of 71.2 lbs along with substantial relief from osteoarthritis pain in first successful Phase 3 trial | Eli Lilly and Company [10] Fourth High-level Meeting of the UN General Assembly on the prevention and control of NCDs and the promotion of mental health and wellbeing (HLM4), September 2025: [11] Thousands of patients from Scotlands poorest areas to benefit from landmark UK government-funded obesity study, November 2025: Thousands of patients from Scotlands poorest areas to benefit from landmark UK government-funded obesity study - GOV.UK [12] Non-Traditional Channels: The Compounded GLP-1 Market

M.AbuelhanaA.McCarronP

PMID: 28233640

Discuss your health-related concerns

This is due to synthesis complexity and purity requirements, says Hari Kiran Chereddi, MD & CEO of HRV Pharma, a contract development and manufacturing company

Clinical Effectiveness for Weight Loss: Novo Nordisks 7.2mg Trials Novo Nordisks phase 3b trial studied 1,407 people with obesity over 72 weeks to test the efficacy and safety of semaglutide at the 7.2mg weekly dose regimen